RUNX3 is a biomarker for determining sensitivity to pheophorbide a-photodynamic therapy in human oral squamous cell carcinoma

Category Primary study
JournalCancer Research
Year 2013
This article has no abstract
Epistemonikos ID: af3080c923691f9e67a3252f49e9186cce6b7de9
First added on: Feb 05, 2025